CancerX Member Organizations

Our members drive the success of CancerX, collaborating to set priorities and practices that will help us harness the full power of innovation to achieve the goals of the Cancer Moonshot.

Impact Supporter

Impact Supporter Innsena

Member Organizations

Our members drive the success of CancerX, collaborating to set priorities and practices that will help us achieve our mission.

Atrium Health UPDATED
AWS
Bulldog Med
Colorado Gov
MEND Nutrition
Orchid Healthcare Solutions Logo 2023 UPDATED
Simbiosys
Slope Updated
Touch BBCA
VA
VivoSense
Volpara Updated

Members also include the National Cancer Institute 

SUPPORT CANCERX

Steering Committee

CancerX’s steering committee provides an additional layer of governance within CancerX’s public-private partnership model.

David Fredrickson, Executive Vice President, Oncology Business, AstraZeneca
AtriumHealth

Rasu Shrestha, Chief Innovation & Commercialization Officer, Atrium Health

Ben Moscovitch, Healthcare and Life Science Public Policy Lead, Americas, Amazon Web Services (AWS)

Sally Werner, Chief Executive Officer, Cancer Support Community

Mary Tolikas, Senior Vice President and Chief Innovation Officer, Dana-Farber Cancer Institute 

Omid Toloui, Vice President, Innovation, Elevance Health

Ryan Smith, Chief Executive Officer, Graphite Health

Najat Khan, Chief Data Science Officer and Global Head, Strategy, Portfolio & Operations, R&D, Janssen Pharmaceutical Companies of Johnson & Johnson

Andrea Downing, Chief Executive Officer, Light Collective

Cait Brumme, Chief Executive Officer, MassChallenge 

Kate Wallis, Vice President of Clinical Innovation, Point32Health

Matt Bettonville, Investor, Yosemite